Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06053255 · ClinicalTrials.gov registry record · NA
Use of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis
A NA study of Sacroiliitis, sponsored by FUSMobile.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06053255 is a NA study of Sacroiliitis that is actively recruiting participants, run by FUSMobile. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06053255, a NA study of Sacroiliitis, is actively recruiting participants, sponsored by FUSMobile.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The Neurolyser XR is a device used to deliver high-intensity focused ultrasound for the ablation of the lateral sacral branch nerve in patients with Sacroiliitis.
Conditions Studied
Interventions
- DEVICE High-intensity focused ultrasound for Sacroiliitis using the Neurolyser XR
Study Locations (1)
Virginia
- University of Virginia, Department of Anesthesiology - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-09-13 |
| Est. Completion | 2026-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06053255
The ClinicalTrials.gov registry entry for NCT06053255 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is FUSMobile, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sacroiliitis appearing as the primary indexed condition, and to 1 intervention - of which High-intensity focused ultrasound for Sacroiliitis using the Neurolyser XR is the first listed.
NCT06053255 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06053255 about?
NCT06053255 is a clinical study titled "Use of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis". The Neurolyser XR is a device used to deliver high-intensity focused ultrasound for the ablation of the lateral sacral branch nerve in patients with Sacroiliitis.
What is the current status of trial NCT06053255?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-09-13. Estimated completion is 2026-12-15.
What conditions does trial NCT06053255 study?
This clinical trial studies the following conditions: Sacroiliitis.
What interventions are being tested in trial NCT06053255?
The interventions under investigation include: High-intensity focused ultrasound for Sacroiliitis using the Neurolyser XR (DEVICE).
Who is sponsoring clinical trial NCT06053255?
This trial is sponsored by FUSMobile, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06053255 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sacroiliitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.